Aug. 11 at 2:56 PM
$MBOT $MBOT I said before Q2 that roughly
$300K+ revenue was my hurdle for calling q2 a clear win. Actual revenue came in around
$241K, so on revenue alone it missed my expectation and went 29k below what I would have excused.
That said, a lot of the commercialization evidence I said could matter more than one quarter's revenue actually showed up.
We now have confirmed Q2 procedure volume growth versus Q1, specifically from existing customers expanding LIBERTY to additional sites and users growing onto the system. We got confirmation of repeat orders from existing customers, an increase in the number of hospital sites actively using LIBERTY, and we have 8 territories, proof of the 12 territory end of year plan. The company also says it has already added additional customers in Q3.
What we don't have are exact active hospital numbers, total procedure counts or procedures per mature account. Those are the numbers I would most like management to start providing.
(1)
